Novita Pharmaceuticalsincis A Privately Held Biopharmaceutical Company Dedicated To Developing First In Class Drugs To Prevent And Treat Cancer Metastasis As Well As To Boost Anti Cancer Immune Responsescancer Metastasis Is The Primary Cause Of Over 90Of Cancer Deaths And Yet There Is No Drug Specifically And Directly Targeting Metastasis On The Market Todaynovita Aims To Address This Problem By Developing Inhibitors Of Fascina Key Protein Highly Expressed In Tumor Cells And Critically Involved In Cell Motility And The Metastasis Of Multiple Tumor Typesadditionallyfascin Is Also Highly Expressed In Antigen Presenting Cells Within The Tumor Microenvironment And Fascin Inhibitorin Combination With Immune Checkpoint Inhibitorscan Synergistically Increase Anti Tumor Immune Response
No conferences found for this company.
| Company Name | Novita Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
